Skip to main content
. Author manuscript; available in PMC: 2013 Jan 1.
Published in final edited form as: Antiviral Res. 2011 Nov 29;93(1):204–208. doi: 10.1016/j.antiviral.2011.11.013

Figure 1.

Figure 1

Kaplan-Meier survival analysis of aerosol-treated animals. All animals treated with 10 mg/kg IV-Cidofovir survived until the end of the study; all untreated controls died from RPX. Aerosol treatments with NanoFOVIR™ protected 50% (3/6), 83% (5/6) and 100% (6/6) of animals treated with 0.5, 1.0 and 1.75 mg/kg against lethal RPX infection. Differences are significant (p<0.05) between positive and negative controls and between untreated controls and animals treated with either 0.5, 1.0 or 1.75 mg/kg aerosol. Circles indicate termination of study.